Dr. Daniel Munro, Assistant Project Scientist at Palmer Lab, was awarded a Pilot Grant for his project titled “Mapping Protein Quantitative Trait Loci in the Heterogeneous Stock Rat Brain to Identify Causal Genes at Substance Use Disorder GWAS Loci.” The Pilot Grant project was selected for support by the Yale/NIDA Neuroproteomics Center, and it is directly aligned … Read more…
A U01 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Giordano de Guglielmo (contact MPI), with Christine Cheng, Dongjun Chung, Abraham Palmer, and Alexander Wanless Smith as MPIs.
The grant is titled “The Genetic Basis of Opioid Dependence Vulnerability in a Rodent Model” and it will start September 30, 2025 and end on May 31, 2030.
[This is a renewal of”The Genetic Basis of Opioid Dependence Vulnerability in a Rodent Model” (U01DA045300), awarded to Dr. Peter Kalivas, Medical University of South Carolina, from 2018-2024.]
Congratulations!
A new R01 grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) was awarded to Dr. Lieselot Carrette, with Dr. Abraham Palmer as co-investigator.
The 4-year grant is titled “Magnetic Resonance Imaging of Outbred Rats with Variable Vulnerability to Compulsive Alcohol Use” and it will start September 20, 2025 and end on August 31, 2029.
Congratulations!